WEKO3
-
RootNode
アイテム
Evaluation of Patient-specific Quality Assurance for Spot-Scanning Carbon Ion Radiotherapy
https://repo.qst.go.jp/records/81596
https://repo.qst.go.jp/records/81596059fee55-3e4a-4c8a-b4ed-db63d62abfb0
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2021-01-08 | |||||
タイトル | ||||||
タイトル | Evaluation of Patient-specific Quality Assurance for Spot-Scanning Carbon Ion Radiotherapy | |||||
言語 | ||||||
言語 | jpn | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
猪俣, 麻美
× 猪俣, 麻美× 鈴木, 優維× 勝間田, 匡× 中島, 猛雄× 古市, 渉× 山岡, 恵士× 菅, 満喜人× 山本, 淳史× 水野, 秀之× 河野, 良介× Asami, Inomata× Yui, Suzuki× Masashi, Katsumata× Nakajima, Takeo× Wataru, Furuichi× Keisi, Yamaoka× Makito, Suga× Atsushi, Yamamoto× Hideyuki, Mizuno× Ryosuke, Kohno |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | [Purpose] In the QST hospital, carbon ion radiotherapy (CIRT) using spot-scanning was started in 2011. In order to check each individual CIRT treatment plan and its treatment delivery, the scanning system and its treatment planning system require dosimetric patient-specific Quality Assurance (PQA) before CIRT. We report results of PQA in half year of 2017. [Methods] For the PQA, all the planned beams are recalculated on a water phantom with treatment planning software. The recalculated dose distributions are compared with the measured distributions using a 2D ionization chamber array at three depth, including 95% area of prescription dose. These are evaluated using 3%/3 mm gamma criteria with a pass threshold of 90%. We analyzed PQA results for about 1500 shots from September 2017 to March 2018, evaluated the pass rate for 10 disease sites with various target volume, energy and measurement depth. [Results] The pass rate for prostate, head and neck, and bone and soft tissue were 95.9%, 99.3%, and 91.5%, respectively. 95.9% of lung plans with low energy beam passed. Overall, 95% of the measured beams for all shots passed the gamma criteria, and were consistent with the plan. Although the rest of 5% failed the criteria, there were no dependence of measurements depth and disease sites in these failures. [Conclusion] The results of the PQA in the second half of FY2017 was analyzed. The overall quality assurance measurement passing rate was 95% for the gamma index criteria of 3%/3 mm. It was obvious that there was no disease sites or target dependency in these pass rates. Therefore, we could ensure the safety of the CIRT treatment plans. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | 第119回日本医学物理学会学術大会 | |||||
発表年月日 | ||||||
日付 | 2020-05-15 | |||||
日付タイプ | Issued |
Share
Cite as
猪俣, 麻美, 鈴木, 優維, 勝間田, 匡, 中島, 猛雄, 古市, 渉, 山岡, 恵士, 菅, 満喜人, 山本, 淳史, 水野, 秀之, 河野, 良介, Asami, Inomata, Yui, Suzuki, Masashi, Katsumata, Nakajima, Takeo, Wataru, Furuichi, Keisi, Yamaoka, Makito, Suga, Atsushi, Yamamoto, Hideyuki, Mizuno, Ryosuke, Kohno, n.d., Evaluation of Patient-specific Quality Assurance for Spot-Scanning Carbon Ion Radiotherapy.
Loading...